Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-23

Clinical Trial Update: Levetiracetam Prophylaxis in Brain Tumor Resection Pilot [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating levetiracetam prophylaxis to prevent seizures after brain tumor resection; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Seizures, Brain Tumor | Phase 3 | Status: NOT_YET_RECRUITING